CAJ | 학술논문

目的评价术前经动脉栓塞化疗(TACE)对肝尾状叶肝细胞癌的疗效.方法回顾性分析2000 年1月至2010年12月29例手术切除的肝尾状叶肝细胞癌患者,其中男性23例,女性6例,中位年龄52岁.根据是否接受术前TACE治疗分为联合组11例和手术组18例,比较2组患者的手术相关结果及5年生存率.结果联合组行TACE后,肿瘤最大径缩小超过33.3％者3例,缩小10.0％～ 33.3％者6例,缩小＜10.0％者2例.联合组平均手术时间(298±39) min,术中出血量(1031 ±310)ml；手术组平均手术时间(281±54) min,术中出血量(868 ± 403) ml；组间差异无统计学意义(t=1.006,P=0.324;t=1.223,p=0.232).联合组共发生并发症6例,死亡1例；手术组共发生并发症4例,无死亡病例；组间差异无统计学意义(x2=0.028,P=0.868；x2=0.633,P=0.426).联合组5年生存率56.8％,手术组5年生存率34.9％,组间差异无统计学意义(P =0.132).结论位于肝尾状叶的肝细胞癌,术前应用TACE不增加手术切除的难度和危险性,而且术前TACE具有改善患者长期生存的趋势.
목적 평개술전경동맥전새화료(TACE)대간미상협간세포암적료효.방법 회고성분석2000 년1월지2010년12월29례수술절제적간미상협간세포암환자,기중남성23례,녀성6례,중위년령52세.근거시부접수술전TACE치료분위연합조11례화수술조18례,비교2조환자적수술상관결과급5년생존솔.결과 연합조행TACE후,종류최대경축소초과33.3％자3례,축소10.0％～ 33.3％자6례,축소＜10.0％자2례.연합조평균수술시간(298±39) min,술중출혈량(1031 ±310)ml；수술조평균수술시간(281±54) min,술중출혈량(868 ± 403) ml；조간차이무통계학의의(t=1.006,P=0.324;t=1.223,p=0.232).연합조공발생병발증6례,사망1례；수술조공발생병발증4례,무사망병례；조간차이무통계학의의(x2=0.028,P=0.868；x2=0.633,P=0.426).연합조5년생존솔56.8％,수술조5년생존솔34.9％,조간차이무통계학의의(P =0.132).결론 위우간미상협적간세포암,술전응용TACE불증가수술절제적난도화위험성,이차술전TACE구유개선환자장기생존적추세.
Objective To evaluate the effect of preoperative transarterial chemoembolization (TACE) on hepatocellular carcinoma located in caudate lobe.Methods Totally 29 cases of caudate lobe hepatocellular carcinoma admitted from January 2001 to December 2010 were analyzed retrospectively.Among the 29 patients,23 were male and the other 6 were female.The median age was 52 years.According to receiving preoperative TACE or not,the 29 cases were divided into two groups:preoperative TACE plus surgery (group A,n =11) and surgery only (group B,n =18).The surgical results and long-term survival were compared between two groups.Results After TACE,the diameter of the tumour reduced by over 33.3％ in 3 patients,10.0％ to 33.3％ in 6 patients,and less than 10.0％ in 2 patients.The duration of surgery and intraoperative blood loss in group A were (298 ± 39) minutes and (1031 ± 310) ml,respectively.The duration of surgery and intraoperative blood loss in group B were (281 ±54) minutes and (868 ±403) ml,respectively.No significant difference was found in terms of these two groups (t =1.006,P =0.324; t =1.223,P =0.232).In addition,6 cases in group A developed complications and 4 cases in group B did so.Only one patient died because of postoperative complication,and this patient belonged to group A.No significant difference was found between two groups (x2 =0.028,P =0.868 ;x2 =0.633,P =0.426).The 5-year survival rate was 56.8％ in group A and 34.9％ in group B.The difference did not reach significant difference (P =0.132).Conclusions For hepatocellular carcinoma located in caudate lobe,preoperative TACE does not significantly increase the surgical difficulty and impair the safety.In addition,preoperative TACE has the tendency to provide benefit to long-term survival.